O'Sullivan B - Search Results

1

CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines.

Brouwer CL, Steenbakkers RJ, Bourhis J, Budach W, Grau C, Grégoire V, van Herk M, Lee A, Maingon P, Nutting C, O'Sullivan B, Porceddu SV, Rosenthal DI, Sijtsema NM, Langendijk JA. Brouwer CL, et al. Radiother Oncol. 2015 Oct;117(1):83-90. doi: 10.1016/j.radonc.2015.07.041. Epub 2015 Aug 13. Radiother Oncol. 2015. PMID: 26277855

2

Radiotherapy alone in patients with advanced nasopharyngeal cancer: comparison with an intergroup study. Is combined modality treatment really necessary?

Chow E, Payne D, O'Sullivan B, Pintilie M, Liu FF, Waldron J, Warde P, Cummings B. Chow E, et al. Radiother Oncol. 2002 Jun;63(3):269-74. doi: 10.1016/s0167-8140(02)00132-9. Radiother Oncol. 2002. PMID: 12142090

3

Limitation of conventional two dimensional radiation therapy planning in nasopharyngeal carcinoma.

Waldron J, Tin MM, Keller A, Lum C, Japp B, Sellmann S, van Prooijen M, Gitterman L, Blend R, Payne D, Liu FF, Warde P, Cummings B, Pintilie M, O'Sullivan B. Waldron J, et al. Radiother Oncol. 2003 Aug;68(2):153-61. doi: 10.1016/s0167-8140(02)00370-5. Radiother Oncol. 2003. PMID: 12972310

4

A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy.

Trotti A, Garden A, Warde P, Symonds P, Langer C, Redman R, Pajak TF, Fleming TR, Henke M, Bourhis J, Rosenthal DI, Junor E, Cmelak A, Sheehan F, Pulliam J, Devitt-Risse P, Fuchs H, Chambers M, O'Sullivan B, Ang KK. Trotti A, et al. Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):674-81. doi: 10.1016/S0360-3016(03)01627-4. Int J Radiat Oncol Biol Phys. 2004. PMID: 14967419 Clinical Trial.

5

Clonogenic survival and cytokinesis-blocked binucleation of skin fibroblasts and normal tissue complications in soft tissue sarcoma patients treated with preoperative radiotherapy.

Akudugu JM, Bell RS, Catton C, Davis AM, O'Sullivan B, Waldron J, Wunder JS, Hill RP. Akudugu JM, et al. Radiother Oncol. 2004 Jul;72(1):103-12. doi: 10.1016/j.radonc.2004.03.010. Radiother Oncol. 2004. PMID: 15236882

6

Wound healing morbidity in STS patients treated with preoperative radiotherapy in relation to in vitro skin fibroblast radiosensitivity, proliferative capacity and TGF-beta activity.

Akudugu JM, Bell RS, Catton C, Davis AM, Griffin AM, O'Sullivan B, Waldron JN, Ferguson PC, Wunder JS, Hill RP. Akudugu JM, et al. Radiother Oncol. 2006 Jan;78(1):17-26. doi: 10.1016/j.radonc.2005.12.001. Epub 2005 Dec 27. Radiother Oncol. 2006. PMID: 16380182

7

Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.

Bourhis J, Overgaard J, Audry H, Ang KK, Saunders M, Bernier J, Horiot JC, Le Maître A, Pajak TF, Poulsen MG, O'Sullivan B, Dobrowsky W, Hliniak A, Skladowski K, Hay JH, Pinto LH, Fallai C, Fu KK, Sylvester R, Pignon JP; Meta-Analysis of Radiotherapy in Carcinomas of Head and neck (MARCH) Collaborative Group. Bourhis J, et al. Lancet. 2006 Sep 2;368(9538):843-54. doi: 10.1016/S0140-6736(06)69121-6. Lancet. 2006. PMID: 16950362 Review.

8

Intraobserver and interobserver variability in GTV delineation on FDG-PET-CT images of head and neck cancers.

Breen SL, Publicover J, De Silva S, Pond G, Brock K, O'Sullivan B, Cummings B, Dawson L, Keller A, Kim J, Ringash J, Yu E, Hendler A, Waldron J. Breen SL, et al. Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):763-70. doi: 10.1016/j.ijrobp.2006.12.039. Epub 2007 Mar 26. Int J Radiat Oncol Biol Phys. 2007. PMID: 17379435

9

Five year results of a randomized trial comparing hyperfractionated to conventional radiotherapy over four weeks in locally advanced head and neck cancer.

Cummings B, Keane T, Pintilie M, Warde P, Waldron J, Payne D, Liu FF, Bissett R, McLean M, Gullane P, O'Sullivan B. Cummings B, et al. Radiother Oncol. 2007 Oct;85(1):7-16. doi: 10.1016/j.radonc.2007.09.010. Radiother Oncol. 2007. PMID: 17920715 Clinical Trial.

10

Hyperfractionated, accelerated radiotherapy for locally advanced head and neck cancer: quality of life in a prospective phase I/II trial.

Ringash J, Lockwood G, O'Sullivan B, Warde P, Bayley A, Cummings B, Kim J, Sellmann S, Waldron J. Ringash J, et al. Radiother Oncol. 2008 May;87(2):181-7. doi: 10.1016/j.radonc.2007.12.028. Epub 2008 Jan 22. Radiother Oncol. 2008. PMID: 18215435 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

890 results

Search Page